Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...